MedPath

Microbubbles and Ultrasound in Stroke Trial: MUST Study

Phase 2
Terminated
Conditions
Acute Ischemic Stroke
Interventions
Radiation: Ultrasound
Registration Number
NCT00222040
Lead Sponsor
University Hospital, Toulouse
Brief Summary

To determine whether transcranial 2-MHz ultrasound combined with intravenous administration of microbubbles improves early recanalization in patients with acute ischemic stroke caused by middle cerebral artery (MCA) proximal occlusion treated with intravenous alteplase within 3 hours of symptom onset.

Detailed Description

Proximal MCA occlusion is recognized using MR or CT angiography performed before inclusion. All patients are treated with alteplase according to current guidelines. In addition, patients randomized in the active group are continuously exposed to transcranial 2-MHz ultrasound for 1 hour combined with intravenous administration of microbubbles. Controls are only treated with alteplase. The ultrasound beam is positioned at the thrombus/blood flow interface using color-coded sonography. Galactose-based microbubbles are administered via continuous intravenous infusion over 40 min.

Early recanalization is assessed using MR or CT angiography 4 to 8 hours after symptom onset. The evaluation of angiograms is performed by 2 neuroradiologists blinded to group of randomization and clinical details. The primary outcome measure is the rate of early recanalization. Recanalization is assessed using the TIMI classification. Secondary endpoints include the rate of symptomatic intracerebral hemorrhage, mortality, and functional outcome on the modified Rankin scale at 3 months.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Acute ischemic stroke
  • MCA proximal occlusion on CT or MR angiography
  • Thrombolysis with intravenous alteplase initiated within 3 hours of stroke onset
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1UltrasoundLevovist
1LevovistLevovist
Primary Outcome Measures
NameTimeMethod
Rate of early recanalization on post-treatment MR or CT angiography. Recanalization is described using the tIMI classification.
Secondary Outcome Measures
NameTimeMethod
Rate of symptomatic intracerebral hemorrhage, mortality, Score on the modified Rankin scale3 months

Trial Locations

Locations (5)

Service de Neurologie, Hôpital Sainte Anne

🇫🇷

Paris, France

Service de Neurologie

🇫🇷

Besancon, France

Service de Neurologie, Hôpital Gui de Chauliac

🇫🇷

Montpellier, France

Service de Neurologie Vasculaire, University Hospital

🇫🇷

Toulouse, France

Service de Neurologie, University Hospital

🇫🇷

Tours, France

© Copyright 2025. All Rights Reserved by MedPath